Lupin receives European Commission approval for biosimilar
New Delhi, Feb 23 (PTI) Drug maker Lupin on Monday said it has received approval from the European Commission for its biosimilar for the treatment of various eye conditions. The company has received approval for Ranluspec (ranibizumab), following the recent positive opinion from the Committee for Medicinal Products for Human Use. Ranibizumab is indicated for…